Aim: The aim of this experimental in vivo investigation was to assess the anti-resorptive effect of low concentration pamidronate on the buccal plate in fresh extraction sockets.
| INTRODUC TI ON
The physiologic modeling and remodeling of the alveolar bone after tooth extraction usually results in marked volumetric changes both in the hard and soft tissues of the residual alveolar ridge. Preclinical studies have clearly demonstrated that these changes are primarily due to vertical and horizontal resorptive changes affecting mainly at the buccal bone (Araujo & Lindhe, 2005; Discepoli et al., 2013) .
Different interventions (ridge preservation techniques) mainly using bone replacement grafts and barrier membranes have been evaluated for their efficacy in reducing these tissue changes and have shown partial efficacy in preserving the vertical and horizontal dimension of the residual alveolar buccal bone crest , thus facilitating implant placement (Ten Heggeler, Slot, & Weijden, 2011) .
However, these interventions may delay bone formation within the extraction socket and will require longer healing times before implants can be placed in their ideal position (Hong et al., 2014) .
One alternative approach to reduce these bone resorptive changes after tooth extraction without interfering with the healing times would be with the use of pharmacologic agents that interfere with the bone remodeling process. Bisphosphonates, due to their mechanism of action of inducing osteoclast inhibition, but at the same time combined with continued osteoblast function, have attracted a lot of attention for their use in the treatment of bone resorptive processes (Fleisch, 2002; Weinstein, Roberson, & Manolagas, 2009 ). Bisphosphonates drugs (e.g., alendronate, pamidronate, and zoledronate) interfere pharmacologically with the bone resorption process resulting in reduced bone resorptionenhanced bone formation, mainly when applied topically in combination with bone substitutes (Houshmand, Rahimi, Ghanavati, Alisadr, & Eslami, 2007; Srisubut, Teerakapong, Vattraphodes, & Taweechaisupapong, 2007) . Previous studies that evaluated the potential of the local application of bisphosphonates on extraction socket healing for ridge preservation have demonstrated Accepted: 11 April 2018 DOI: 10.1111 
O R I G I N A L A R T I C L E
Anti-resorptive effect of pamidronate on extraction socket wall in dogs initially positive outcomes (Altundal & Guvener, 2004; Fischer, Stavropoulos, Calvo-Guirado, Schneider, & Fickl, 2015) . However, these preliminary investigations applied bisphosphonates inside the extraction socket, what delayed the healing of the socket.
Another possible limitation, mainly when bisphosphonates are applied at high concentrations, is the occurrence of wound dehiscence in the soft tissues and/or osteonecrosis lesions hard tissues (Moller et al., 2014) .
To overcome these limitations, we have hypothesized that the application of bisphosphonates at low concentrations in a collagen matrix (CM) applied on the outer surface of the buccal bone crest may prevent the resorptive changes occurring mainly in this bone plate. To test this hypothesis, we have designed this in vivo experimental study.
| MATERIAL AND ME THODS
This preclinical in vivo investigation was designed following to the modified ARRIVE guidelines for preclinical research including the use of a reduced the number of experimental animals, refined procedures to improve animal welfare, and replacement of animal use where possible (Vignoletti & Abrahamsson, 2012) . This study was designed as a randomized block, examiner-blind split-mouth design experimental study carried out in six adult beagle dogs (n = 6). The animal selection, management, and the experimental protocol were approved by the Animal Care and Use Committee, Yonsei Medical Center, Seoul, Korea (Permission no. 2013-0317-4).
| Experimental animals, housing, and husbandry
Six male beagle dogs aged 12 months and weighing approximately 15 kg were used. The animals were housed at a room temperature of 15-20°C and a humidity of >30%. All animals were observed 2 weeks prior to the start of the study to determine their general health status, and during this quarantine period, there were no signs or symptoms of any disease. These animals were also examined to ensure the absence of oral and dental diseases that may interfere with the tested interventions. On the day of surgery each animal was examined to document its general health status and determine that it qualified for final inclusion in the study. Supragingival scaling and plaque control were performed to each dog prior to surgery.
At the day of surgery, general anesthesia was induced after inhalation anesthesia (Gerolan, Choongwae Pharmaceutical, Seoul, Korea) through the intramuscular injection of xylazine (2 mg/kg; Rompun, Bayer Korea, Seoul, Korea) and ketamine (10 mg/kg; Ketalar, Yuhan, Seoul, Korea), together with the intravenous injection of atropine (0.05 mg/kg; Kwangmyung Pharmaceutical, Seoul, Korea). Local infiltrative anesthesia (2% lidocaine HCL with epinephrine 1:80,000; Kwangmyung Pharmaceutical) was also applied at the surgical site.
Post-surgically, antibiotics (20 mg/kg intramuscular cefazolin sodium, Yuhan, Seoul, Korea), anti-inflammatory, and analgesic medications (Ketorolac, Hana Pharm., Gyeonggi-do, Korea; Meloxicam, Boehringer Ingelheim, Bogota D.C., Colombia) were administered for 3 and 7 days, respectively. The surgical wounds were cleaned by irrigation with 0.2% chlorhexidine solution (Hexamedin, Bukwang Pharmaceutical, Seoul, Korea) on a daily basis. The sutures were removed after 10 days, and the dogs were maintained on a soft diet throughout the healing period before being sacrificed after 12 weeks with an intravenous overdose of sodium pentobarbital.
| Experimental procedures

| Material preparation
The collagen matrix (CM) used as carrier material is a double-layered matrix composed of chemically cross-linked type I collagen derived from bovine tendons (Collagen Graft®, Genoss, Suwon, South Korea). These CM with a size of 5 mm 10 mm were soaked in either 15 mg/ml pamidronate (test group; Hanlim Company, Yongin, Korea) or saline (control group) for 10 min immediately before their intrasurgical application covering the buccal bone plate. The concentration of pamidronate used in the present study was calculated from a previous in vitro study, based on the minimum bisphosphosphonate concentration needed to achieve significant osteoclast activity (Liao et al., 2013) . In each dog, test and control CM were randomly assigned to one of the two lower third premolars. Allocation to the treatment group was done randomly using a computer-generated randomization list (IBM SPSS Statistics V20. (c) JM. Domenech) and concealed by envelopes until the time of CM application. 
| Surgical procedure
| Sample size
Sample size calculation was based on estimations from a previous preclinical study (Fickl, Zuhr, Wachtel, Bolz, & Huerzeler, 2008 ) using the changes in the histological bone levels at the buccal side as the primary variable. The clinically relevant difference was set at 1 mm with a standard deviation between 0.5 and 0.7 mm. The probability of a type I error was set at 0.5, while the probability of a Type II error was set at 0.2, thus achieving 90% power. A sample size of six animals was calculated per experimental group.
| Radiogaphic analyses
The block sections of the experimental sites were harvested and immersed in 5% formic acid for 2 weeks. A micro-computed tomographic (CT) scan was performed (SkyScan 1072, SkyScan, Aartselaar, Belgium) at a resolution of 35 µm (achieved using 100 kV and 100 µA) and reconstructed using three-dimensional software (OnDemand3D, Cybermed, Seoul, Korea).
| Histologic and histomorphometric analyses
After rinsing the block sections in sterile water, they were decalcified, trimmed, dehydrated in graded ethanol series, embedded in paraffin, and cut into serial sections at a thickness of 5 µm along the longitudinal axis of each tooth. We selected the two most central sections of distal root of the third premolar and once stained with hematoxylin-eosin and Masson's trichrome, histological measurements were performed with the aid of a stereomicroscope (MZFLIII, Leica, Wetzlar, Germany) and a light microscope (BX-50, Olympus Optical, Tokyo, Japan).
All the histomorphometric measurements were analyzed by using a PC-based image analysis system (Image-Pro Plus, Media Cybernetics, Silver Spring, MD, USA) with a reference to previous study (Araujo & Lindhe, 2005) . With the use of cross-sectional micro-CT images, the remaining mesial root of the third premolar was used as a reference to establish the long axis of alveolar ridge, based on the assumption that both mesial and distal roots would have the 2. Horizontal ridge width. Lines perpendicular to the tooth axis line were drawn at 1, 2, and 3 mm below the lingual crest, at which the horizontal ridge width was calculated to yield HRW1, HRW2, and HRW3, respectively.
The regions of interest (ROI) (1 mm width × 1 mm height) were set along with the long axis of alveolar ridge at 1, 3, and 5 mm below the lingual crest (coronal, middle, and apical, respectively). Within these areas, the percentages of the amount of woven bone, mature bone, bone marrow, and connective tissue were identified and measured ( Figure 2 ).
| Experimental outcomes
The primary outcome of this study was the VBL, while the other histomorphometric parameters were measured as secondary outcomes. Shapiro-Wilk test was used to test the normality of the distribution.
| Statistical analysis
As all linear measurements were normally distributed, paired t tests were used to evaluate the inter-group differences. The dimensional measurements, however, were not normally distributed and hence, the Wilcoxon signed rank tests were used (p < .05). The statistical analysis was performed using SPSS software (version 22.0; SPSS, Chicago, IL, USA).
| RE SULTS
| Number of animals analyzed
All six dogs were included in the histomorphometric analysis.
| Clinical analysis
After 1 week of healing, one dog in each of the control (dog no. 1) and test (dog no. 4) groups showed delayed soft-tissue healing demonstrating a wound dehiscence. In both cases, the coronally advanced flap was loosely attached to the wound site with excess blood clots. Secondary healing had occurred at 2 weeks post-operatively. The horizontal ridge widths and the thickness of the buccal and lingual bone measured after tooth extraction did not differ significantly between the groups Table S1 .
| Radiographic analysis
In the reconstructed images, there were clear differences between the groups, being the buccal bone plate well maintained in the test group, but not in control group (Figure 3 ). In the test group, the opening of socket maintained its original shape and was partially filled with mineralized tissue, in contrast with the control group, presenting complete closure of socket entrance in five of the six specimens. In the occlusal view, the opening of socket maintained its original shape and was partially filled with mineralized tissue, in contrast with the control group, presenting complete closure of socket entrance in five of the six specimens.
| Histologic and histomorphometric analyses
All of the histologic slides are presented in Figure 4 . The healing pattern clearly differed between the test and control groups. Every specimen of the test group with the exception of dog no. 4 showed less resorption of the buccal bone plate than the control group.
Coronal third of the buccal bone plate was resorbed in most of the The histomorphometric data are presented in Table 1 and HRW-2 and -3 than the control group, although these differences were not statistically significant (p > .05). In the coronal part, the test group showed a significantly higher amount of woven bone when compared to the control group (5.92 ± 5.28 vs.
0.43 ± 0.68%, p = .043). However, no differences in the amounts of bone marrow were found at any of the three regions of interests (p > .05).
| Adverse events
No systemic adverse events were observed in this study.
| D ISCUSS I ON
This in vivo study was designed to investigate the local effects of the application of a CM soaked with low concentration bisphosphonates on the buccal bone plate in fresh extraction sockets. The most no- The mean vertical distance between the buccal and lingual bone crest was only 0.5 mm in the test group, represented approximately 20% of that in the control group. This distance was also significantly lower than those reported in similar experimental studies evaluating ridge preservation protocols (mean 2.8-3.2 mm after 4 months of healing) (Araujo & Lindhe, 2005; Fickl et al., 2008) . The horizontal measurements demonstrated that the resulting residual alveolar ridge was wider in the test group when compared with the control group, especially at 1 mm below the lingual crest. These results would, therefore, result in residual ridges with wider bone availability for implant placement and reduced need for additional complex surgical procedures (e.g., guided bone regeneration).
The resulting position of the buccal bone crest, 2.2 mm apical of its lingual counterpart in the control group, was larger than what has been reported for the spontaneous healing of alveolar sockets (VBLs of 1-2 mm) (Discepoli et al., 2015; Vignoletti et al., 2009 ).
This discrepancy can be explained by differences in the anatomy of the residual bone walls among the different animals used in these experimental studies. Also, the reflection of the periosteal flap in the present study could have influenced the pronounced resorption of buccal bone by leading to osteoclastic activity (Araujo & Lindhe, 2005; Bragger, Pasquali, & Kornman, 1988; Wood, Hoag, Donnenfeld, & Rosenfeld, 1972) .
Bisphosphonate mechanism of action involves the competitive binding on enzymes that utilize pyrophosphate and thus, it inhibits osteoclastic activity leading these cells to apoptosis, while not affecting the physiology of osteoblasts. Previous animal experiments using bisphosphonates in bone augmentation procedures have also shown enhanced bone regeneration and less bone resorption (Houshmand et al., 2007; Srisubut et al., 2007) . Bone regeneration has often been increased by bisphosphonates, which is probably an indirect effect of the inhibition of bone resorption (Rodan, 1997) . It was reported that bisphosphonates were effective in reducing bone loss but ineffective for inducing bone formation; thus, this should be applied locally in procedures where bone resorption is expected (Yaffe, Kollerman, Bahar, & Binderman, 2003) . In light of these effects, we hypothesized that the local administration of bisphosphonate would limit the amount of buccal bone resorption after tooth extraction and would result in preserved residual alveolar ridges, as demonstrated with the results from the present experimental study.
The application of bisphosphonates in extraction sockets has been seldom evaluated. Pamidronate absorbed on a porcine-derived bone replacement graft was locally applied in fresh extraction sockets in two dogs and it was reported reduced horizontal dimensional changes resulting in wider bone crests (Fischer et al., 2015) . When compared the effects of this porcine-derived bone replacement graft with or without pamidronate application, it was reported that the addition of pamidronate enhanced new bone formation after 4 and 8 weeks of healing (Lozano-Carrascal et al., 2016) . In a clinical study evaluating the local effects of collagen sponge soaked in alendronate in 20 patients, in the test group, the ridge resorption was prevented by 44.38%, and in the control group by 22.8% (De Sarkar et al., 2015) .
In contrast, it was reported that the healing of the coronal part of the extraction socket was considerably delayed or impaired at the sites of pamidronate administration (Fischer et al., 2015) . In this study, the authors revealed that none of the socket entrances in the test sites were bridged by newly formed bone after 4 months of healing but rather with soft connective tissue encapsulated bone substitute particles. Similarly, the healing of the inside of the socket was considerably delayed when bisphosphonates were topically applied in extraction sockets revealing delayed formation of trabecular bone and bone marrow. However, different from this reported study, we applied the pamidronate-loaded CM only to the entrance of the sockets and the outer surface of buccal bone, but not to the inner part of the ex- Future studies should test the most effective placement site of the bisphosphonate for the ideal inhibition of the resorptive changes without affecting the bone healing process within the extraction socket.
Soft-tissue dehiscence occurred in one dog of the test group; however, it also occurred in one dog in the control group, what may suggest that bisphosphonate may not be the responsible for this delayed soft-tissue healing. Although differences between groups may not be significant once the complete healing of the extraction socket has occurred, the described incomplete corticalization at 12 weeks could jeopardize the proper installation of a dental implant, and therefore, the clinical use of pamidronate may not be recommended.
Another clear problem associated with the local application of bisphosphonates is the occurrence of necrosis of bone and overlying soft tissue. The effect of bisphosphonate on the surface resorption of autogenous block bone graft in minipigs was evaluated (Moller et al., 2014) . The application of bisphosphonates was associated with significantly less bone resorption, but necrosis of the bone and the covering periosteum occurred in some specimens, specifically those receiving high doses of bisphosphonate.
Previous studies have mainly used either alendronate or pamidronate at various concentration ranges. Pamidronate was applied to extraction sockets at a concentration of 90 mg/ml in two experimental studies (Fischer et al., 2015; Lozano-Carrascal et al., 2016) , while alendronate was injected subcutaneously at 0.25 mg/ kg in rats (Altundal & Guvener, 2004) or was applied at 20 mg/ml in a clinical trial (De Sarkar et al., 2015) . These heterogeneities in dose applications highlight the need of studies evaluating the ideal dosage of these bone repairing drugs.
Alendronate and pamidronate have similar molecular structures, both containing a nitrogen group, and appear to have a similar mechanism of action; however, alendronate is approximately 10 times more active than pamidronate in inhibiting bone resorption (Jack DeRuiter, 2002; Schenk, Eggli, Fleisch, & Rosini, 1986) . In the present study, we have used 15 mg/ml pamidronate, which is only 20% of the concentration used in previous dog experiments. Further studies are needed to clarify the most appropriate type of bisphosphonate and its concentration for preventing resorption without inducing toxicity. Also, further investigations are necessary to observe the effects of bisphosphonate at different concentrations and at more time points, and to modify the method of administration based on the positive results obtained in this study.
Within the limitations of this study, it can be concluded that the local application of pamidronate onto the outer surface of buccal bone significantly reduced the dimensional changes at early stages of the socket healing process both vertically and horizontally. The study was partially supported by the Osteology Foundation, Switzerland with a research scholarship grant (16-004) to Jae-Kook
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